secwatch.observer — SEC 8-K summary
======================================

Issuer:     GlobeStar Therapeutics Corp (—)
CIK:        0001502152
Form:       8-K
Filed at:   2023-06-27T23:59:59+00:00
Accession:  0001161697-23-000380
Event type: other_material
Sentiment:  negative
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GlobeStar Therapeutics dismisses auditor M&K, engages Fruci & Associates; prior reports had going concern note
--------------------------------------------------------------------------------

- Effective June 20, 2023, board approved dismissal of M&K CPAS, PLLC and engagement of Fruci & Associates II, PLLC as auditor for FY ending Sept 30, 2023.
- No disagreements or reportable events in fiscal years 2021-2022 or interim period; M&K's reports contained a going concern explanatory paragraph.
- Company provided M&K with a copy of the disclosures and requested a letter; M&K's letter dated June 27, 2023 is filed as Exhibit 16.1.
- No prior consultations with Fruci & Associates on accounting principles or audit opinion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1502152/000116169723000380/0001161697-23-000380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1502152/000116169723000380/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-23-000380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer